Home Articles List Article Information
Benha Medical Journal
Journal Archive
Volume Volume 41 (2024)
Issue Issue 7
(special issue radiology)
Issue Issue 6
(academic issue)
Issue Issue 5
Issue Issue 4
(special issue gynecology and obstetrics)
Issue Issue 3
(special issue cardiology)
Issue Issue 2
Issue Issue 1
(annual conference issue)
Issue Special issue (Pediatrics)
Volume Volume 40 (2023)
Volume Volume 39 (2022)
Volume Volume 38 (2021)
Volume Volume 37 (2020)
Volume Volume 36 (2019)
El-Din, O., Amin, M., Abdelsatar, S. (2024). Evolving Role of Whole-Body 18 F-FDG PET/CT in Post Therapeutic Evaluation of Ovarian Malignancy. Benha Medical Journal, 41(1), 288-297. doi: 10.21608/bmfj.2024.265862.2006
Ossama Zein El-Din; Mariem Mahmoud Amin; Sherif Ahmed Elrefai Abdelsatar. "Evolving Role of Whole-Body 18 F-FDG PET/CT in Post Therapeutic Evaluation of Ovarian Malignancy". Benha Medical Journal, 41, 1, 2024, 288-297. doi: 10.21608/bmfj.2024.265862.2006
El-Din, O., Amin, M., Abdelsatar, S. (2024). 'Evolving Role of Whole-Body 18 F-FDG PET/CT in Post Therapeutic Evaluation of Ovarian Malignancy', Benha Medical Journal, 41(1), pp. 288-297. doi: 10.21608/bmfj.2024.265862.2006
El-Din, O., Amin, M., Abdelsatar, S. Evolving Role of Whole-Body 18 F-FDG PET/CT in Post Therapeutic Evaluation of Ovarian Malignancy. Benha Medical Journal, 2024; 41(1): 288-297. doi: 10.21608/bmfj.2024.265862.2006

Evolving Role of Whole-Body 18 F-FDG PET/CT in Post Therapeutic Evaluation of Ovarian Malignancy

Article 26, Volume 41, Issue 1, March and April 2024, Page 288-297  XML PDF (623.13 K)
Document Type: Original Article
DOI: 10.21608/bmfj.2024.265862.2006
View on SCiNiTO View on SCiNiTO
Authors
Ossama Zein El-Din1; Mariem Mahmoud Amin email 2; Sherif Ahmed Elrefai Abdelsatarorcid 3
1Professor of Radiology, Maadi Military Hospital
2Department of diagnostic and interventional radiology Faculty of Medicine Benha University
3Lecturer of radiodiagnosis , Benha university , Egypt
Abstract
Background: Ovarian cancer, the most lethal among gynecological malignancies, often presents at an advanced stage, complicating initial diagnosis and treatment planning. Imaging techniques, notably 18F-FDG PET/CT, have emerged as pivotal tools in the post-therapeutic evaluation of ovarian malignancies, aiding in accurate staging, recurrence detection, and therapeutic planning. This study aimed to evaluate the role of whole-body 18F-FDG PET/CT in detecting the loco-regional recurrence and distant metastasis in ovarian cancer patients. Methods: This study was carried out in private radiology centers from May 2022 to February 2023 for known patients of ovarian cancers underwent therapy, coming for annual follow up with suspected recurrence, and/or distant metastasis clinically or laboratory. Our study included 25 patients all of them performed PET- CT and diagnosed with ovarian malignant lesions underwent surgical management followed by chemotherapy, however their annual tumor marker assessment showed elevated CA 125 and were referred for PETCT assessment. Results: PET- CT was found to be more sensitive in detecting the peritoneal deposits (less than 5 mm in diameter) especially the peripherally located perihepatic ones which couldn’t be detected by the CT or CE-CT images, in 5 cases out of 25 (20%).
Keywords
18 F-FDG; PET/CT; Ovarian Malignancy
Statistics
Article View: 51
PDF Download: 130